Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Foto på Patrik Edén

Patrik Edén

Universitetslektor

Foto på Patrik Edén

A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients : Study protocol of the SCAN-B resilience study

Författare

  • Ulrika Axelsson
  • Lisa Rydén
  • Per Johnsson
  • Patrik Edén
  • Johanna Månsson
  • Ingalill Rahm Hallberg
  • Carl A.K. Borrebaeck

Summary, in English

Background: Individual patients differ in their psychological response when receiving a cancer diagnosis, in this case breast cancer. Given the same disease burden, some patients master the situation well, while others experience a great deal of stress, depression and lowered quality of life. Patients with high psychological resilience are likely to experience fewer stress reactions and better adapt to and manage the life threat and the demanding treatment that follows the diagnosis. If this phenomenon of mastering difficult situations is reflected also in biomolecular processes is not much studied, nor has its capacity for impacting the cancer prognosis been addressed. This project specifically aims, for the first time, to investigate how a breast cancer patient's psychological resilience is coupled to biomolecular parameters using advanced "omics" and, as a secondary aim, whether it relates to prognosis and quality of life one year after diagnosis. Method: The study population consists of newly diagnosed breast cancer patients enrolled in the Sweden Cancerome Analysis Network - Breast (SCAN-B) at four hospitals in Sweden. At the time of cancer diagnosis, the patient fills out the standardized method to measure psychological resilience, the "Connor-Davidson Resilience scale" (CD-RISC), the quality of life measure SF-36, as well as providing social and socioeconomic variables. In addition, one blood sample is collected. At the one-year follow-up, the patient will be subjected to the same assessments, and we also collect information regarding smoking, exercise habits, and BMI, as well as patients' trust in the treatment and their satisfaction with the care and treatment. Discussion: This explorative hypothesis-generating project will pave the way for larger validation studies, potentially leading to a standardized method of measuring psychological resilience as an important parameter in cancer care. Revealing the body-mind interaction, in terms of psychological resilience and quality of life, will herald the development of truly personalized psychosocial care and cancer intervention treatment strategies. Trial registration: This is a retrospectively registered trial at ClinicalTrials.gov, ID: NCT03430492on February 6, 2018.

Avdelning/ar

  • Institutionen för immunteknologi
  • Bröstcancerkirurgi
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
  • Institutionen för psykologi
  • Beräkningsbiologi och biologisk fysik - Genomgår omorganisation
  • Pufendorfinstitutet
  • Hälsofrämjande komplexa interventioner
  • Create Health

Publiceringsår

2018-08-06

Språk

Engelska

Publikation/Tidskrift/Serie

BMC Cancer

Volym

18

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

BioMed Central (BMC)

Ämne

  • Cancer and Oncology

Nyckelord

  • Biomolecular parameters
  • Body and mind
  • Breast cancer
  • CD-RISC
  • Epigenetics
  • Psychological resilience
  • Quality of life
  • SF36

Status

Published

Forskningsgrupp

  • Breast Cancer Surgery
  • Health-promoting Complex Interventions

ISBN/ISSN/Övrigt

  • ISSN: 1471-2407